FDA Drug Application (020780) for CIPRO by BAYER HLTHCARE

Back to FDA Applications sponsored by BAYER HLTHCARE

Application Number020780
Product Number001
FormFOR SUSPENSION;ORAL
Dosage250MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCIPRO
Active IngredientCIPROFLOXACIN

Active IngredientCount
List of drugs with Active Ingredient CIPROFLOXACIN10
List of drugs with Active Ingredient CIPROFLOXACIN HYDROCHLORIDE9


Back to FDA Applications sponsored by BAYER HLTHCARE